-
Mashup Score: 11HER2 Breast Cancer Twitter Chats: Exploring the Past and Future of HER2 Testing in Breast Cancer - 1 year(s) ago
This activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the latest evidence regarding HER2-low breast cancer and HER2 testing guidelines. This Twitter Chat will review historic and emerging trends in HER2 testing for patients with breast…
Source: store.ascp.orgCategories: Latest Headlines, PathologyTweet
-
Mashup Score: 0HER2-low Education and Resources - 1 year(s) ago
MicrolearningChallenges in Testing Across the HER2+ Breast Cancer SpectrumThis CME/CMLE-accredited, case-based microlearning activity is designed to help pathologists and laboratory professionals increase their knowledge, skills, and competence in testing and diagnosing breast cancer across the HER2 spectrum.Every few days, participants will be emailed or sent several questions through the…
Source: www.ascp.orgCategories: Latest Headlines, PathologyTweet-
Please view our other HER2 breast cancer #CME activities and resources here: https://t.co/piWqmRSEgH #HER2low #PathTwitter #BreastPath
-
-
Mashup Score: 10
HER2 expression is often negative or low in primary breast cancers (BCs) but its changes with disease progression remain poorly known. We aimed to estimate them between primary and recurrent tumours, and identify predictive factors. We compared the HER2 status, and clinical and pathological characteristics by its evolution category (stable or changed), between all primary BCs and matched…
Source: NatureCategories: Latest Headlines, PathologyTweet-
Q4: What were some of the key points from this recent @BrJCancer article on anticipating changes in the HER2 status of breast cancers with disease progression? https://t.co/8OfwxnKXeg #HER2low #PathTwitter #BreastPath @israhkhan @Baskotacytopath @mkw_MD @KhouryThaer
-
-
Mashup Score: 0Abstract 5388: A unified computational pathology method to quantify HER2 expression from raw IHC and IF images in breast cancer - 1 year(s) ago
Abstract. Background: The development of automated quantitative methods to measure biomarker expression such as HER2 aims at reducing the subjective variability of pathologist-performed biomarker assessment of immunohistochemically (IHC) stained tissue slides. As an example, the deep learning-based Quantitative Continuous Scoring (QCS) algorithm [1] enables the objective measurement of biomarker…
Categories: Latest Headlines, PathologyTweet-
Q5: What were the findings from the 2023 @AACR Abstract: A unified computational pathology method to quantify HER2 expression from raw IHC and IF images? https://t.co/JCIreL1Mab #HER2low #PathTwitter #BreastPath @israhkhan @Baskotacytopath @mkw_MD @KhouryThaer
-
-
Mashup Score: 9HER2 Breast Cancer Twitter Chats: Exploring the Past and Future of HER2 Testing in Breast Cancer - 1 year(s) ago
This activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the latest evidence regarding HER2-low breast cancer and HER2 testing guidelines. This Twitter Chat will review historic and emerging trends in HER2 testing for patients with breast…
Source: store.ascp.orgCategories: Latest Headlines, PathologyTweet-
Today’s CME Twitter Chat will focus on “HER2-low” breast cancer. #HER2low #PathTwitter #BreastPath Get your #CME credits here: https://t.co/s5QjD6xlF4
-
-
Mashup Score: 0HER2-low Education and Resources - 1 year(s) ago
MicrolearningChallenges in Testing Across the HER2+ Breast Cancer SpectrumThis CME/CMLE-accredited, case-based microlearning activity is designed to help pathologists and laboratory professionals increase their knowledge, skills, and competence in testing and diagnosing breast cancer across the HER2 spectrum.Every few days, participants will be emailed or sent several questions through the…
Source: www.ascp.orgCategories: Latest Headlines, PathologyTweet-
Find additional HER2 Breast Cancer CME/CMLE here: https://t.co/piWqmRSEgH https://t.co/9hhNbgYLjX #HER2low #PathTwitter #BreastPath
-
-
Mashup Score: 0HER2 Breast Cancer Twitter Chats: Optimizing Laboratory Practices for the Assessment of HER2-low - 1 year(s) ago
This activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the latest evidence regarding HER2-low breast cancer and HER2 testing guidelines. This Twitter Chat will explore how pathologists and laboratory professionals are optimizing laboratory practices…
Source: store.ascp.orgCategories: Latest Headlines, PathologyTweet-
Thank you for joining today’s #CME Twitter Chat! Please claim your #CME here https://t.co/r2WnbAl8X6 #HER2low #PathTwitter #BreastPath
-
-
Mashup Score: 0HER2-low Education and Resources - 1 year(s) ago
MicrolearningChallenges in Testing Across the HER2+ Breast Cancer SpectrumThis CME/CMLE-accredited, case-based microlearning activity is designed to help pathologists and laboratory professionals increase their knowledge, skills, and competence in testing and diagnosing breast cancer across the HER2 spectrum.Every few days, participants will be emailed or sent several questions through the…
Source: www.ascp.orgCategories: Latest Headlines, PathologyTweet-
Please view our other HER2 breast cancer #CME activities and resources here: https://t.co/piWqmRSEgH #HER2low #PathTwitter #BreastPath
-
-
Mashup Score: 0HER2 Breast Cancer Twitter Chats: Optimizing Laboratory Practices for the Assessment of HER2-low - 1 year(s) ago
This activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the latest evidence regarding HER2-low breast cancer and HER2 testing guidelines. This Twitter Chat will explore how pathologists and laboratory professionals are optimizing laboratory practices…
Source: store.ascp.orgCategories: Latest Headlines, PathologyTweet-
Today’s CME Twitter Chat will focus on “HER2-low” breast cancer. #HER2low #PathTwitter #BreastPath Get your #CME credits here https://t.co/r2WnbAl8X6
-
-
Mashup Score: 0HER2-low Education and Resources - 1 year(s) ago
MicrolearningChallenges in Testing Across the HER2+ Breast Cancer SpectrumThis CME/CMLE-accredited, case-based microlearning activity is designed to help pathologists and laboratory professionals increase their knowledge, skills, and competence in testing and diagnosing breast cancer across the HER2 spectrum.Every few days, participants will be emailed or sent several questions through the…
Source: www.ascp.orgCategories: Latest Headlines, PathologyTweet-
Find additional HER2 Breast Cancer CME/CMLE here: https://t.co/piWqmRSEgH https://t.co/lizAXiFV3c #HER2low #PathTwitter #BreastPath
-
Thank you for joining today’s #CME Twitter Chat! Please claim your #CME here https://t.co/s5QjD6xlF4 #HER2low #PathTwitter #BreastPath